title: Relapse of myeloid neoplasm with eosinophilia and PDGFRA rearrangement after imatinib discontinuation in a pediatric patient.
authors.affiliation: Department of Pediatric Hematology and Oncology, H.C. Andersen Children's Hospital, Odense University Hospital, University of Southern Denmark, Odense, Denmark.
authors.forename: Mathias
authors.initials: M
authors.lastname: Rathe
authors.forename: Eckhard
authors.initials: E
authors.lastname: Schomerus
authors.forename: Peder Skov
authors.initials: PS
authors.lastname: Wehner
authors.forename: Thomas Kielsgaard
authors.initials: TK
authors.lastname: Kristensen
authors.forename: Michael Boe
authors.initials: MB
authors.lastname: Møller
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects; D001549:Benzamides / Q000009:adverse effects*; D002675:Child, Preschool; D004802:Eosinophilia / Q000139:chemically induced* / Q000235:genetics*; D005260:Female; D015321:Gene Rearrangement; D006801:Humans; D000068877:Imatinib Mesylate; D009196:Myeloproliferative Disorders / Q000188:drug therapy*; D009364:Neoplasm Recurrence, Local / Q000139:chemically induced* / Q000235:genetics; D010879:Piperazines / Q000009:adverse effects*; D011379:Prognosis; D011743:Pyrimidines / Q000009:adverse effects*; D020796:Receptor, Platelet-Derived Growth Factor alpha / Q000235:genetics*; D028761:Withholding Treatment
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D020796:Receptor, Platelet-Derived Growth Factor alpha